Arkema S.A. (LON:0IB0)
53.20
-0.10 (-0.19%)
At close: Dec 12, 2025
Arkema Market Cap
Arkema has a market cap or net worth of 3.51 billion as of December 15, 2025. Its market cap has decreased by -23.81% in one year.
Market Cap
3.51B
Enterprise Value
5.72B
Revenue
8.06B
Ranking
n/a
PE Ratio
31.70
Stock Price
53.20
Market Cap Chart
Since May 18, 2006, Arkema's market cap has increased from 1.32B to 3.51B, an increase of 165.79%. That is a compound annual growth rate of 5.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 3.51B | -23.50% |
| Dec 31, 2024 | 4.59B | -30.97% |
| Dec 29, 2023 | 6.65B | 20.05% |
| Dec 30, 2022 | 5.54B | -27.94% |
| Dec 31, 2021 | 7.69B | 20.26% |
| Dec 31, 2020 | 6.40B | 5.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 208.48B |
| HSBC Holdings | 190.63B |
| Shell | 154.12B |
| Unilever | 107.01B |
| Rio Tinto Group | 96.53B |
| British American Tobacco p.l.c. | 92.16B |
| Rolls-Royce Holdings | 91.78B |
| GSK plc | 73.26B |